Crystal gazing: Biotech's financial outlook

Nature Biotechnology

Volumn 24, Issue 3, 2006, Pages 261-264

  Schmidt, Eric ^a   Strupp Jr , David J ^b  

^a Cowen and Co ^*  (United States)

^b ThinkEquity Partners LLC

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CAPITAL; DRUG COST; DRUG INDUSTRY; DRUG RESEARCH; ECONOMICS; FINANCIAL MANAGEMENT; INDUSTRY; INVESTMENT; LICENSING; MANAGEMENT; MARKET; NOTE; PATENT; PRIORITY JOURNAL; PROFIT;

BIOTECHNOLOGY; CAPITAL FINANCING; ENTREPRENEURSHIP; FORECASTING; INVESTMENTS; MARKETING;

EID: 33644864036     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0306-261a     Document Type: Note

References (0)